Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$87.69 for US$1.32M under a trading plan, leaving 582,540 shares. Filed Jul 2, 2026 (Form 4).

Sold
15,000 shares
Price
US$87.69 average (US$87.44 to US$88.91)
Value
US$1.32M
Holding after
582,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockSale10,176US$87.44587,364Direct
Jul 1, 2026Common StockSale4,234US$88.12583,130Direct
Jul 1, 2026Common StockSale590US$88.91582,540Direct

Source

View original at SEC

Related